Cancer Pipeline Milestones Coming Fast as Regulators Revisit Research Priorities
Funding and Research Challenges: The outlook for cancer research is uncertain due to potential cuts in scientific funding and increased regulatory scrutiny of mRNA vaccines, despite rising cancer incidence among younger populations and the emergence of biotech companies with promising treatments.
Oncolytics Biotech Progress: Oncolytics Biotech Inc. has reported significant clinical data supporting its oncolytic virus, pelareorep, showing improved survival rates in pancreatic and breast cancer patients, while also preparing for future partnerships and trials to advance its development.
Trade with 70% Backtested Accuracy
Analyst Views on GOVX
About GOVX
About the author
Tilray Brands Reports Q2 Earnings Beat, Shares Surge 7.3%
- Earnings Beat: Tilray Brands reported Q2 earnings of $0.01 per share, surpassing the market expectation of a $0.20 loss, indicating a significant improvement in profitability that boosts investor confidence.
- Revenue Growth: The company achieved quarterly revenue of $217.51 million, exceeding the consensus estimate of $210.95 million, demonstrating success in market demand and sales strategies, which further solidifies its market position.
- Stock Price Surge: Following the positive earnings report, Tilray Brands' shares rose 7.3% to $9.80 in pre-market trading, reflecting investor optimism about the company's future growth potential.
- Positive Market Reaction: The strong performance post-earnings release may attract more investor attention, enhancing the company's appeal in a competitive market landscape.
Dow Rises by More Than 200 Points; Conagra Stock Declines Following Q2 Earnings Report
U.S. Stock Market Performance: U.S. stocks rose this morning, with the Dow Jones gaining over 200 points, while the NASDAQ and S&P 500 also saw increases of 1.03% and 0.73%, respectively.
Sector Movements: Information technology shares increased by 1.6%, while real estate stocks experienced a slight decline of 0.1%.
Notable Stock Movements: Conagra Brands Inc. shares fell over 4% despite beating earnings estimates, while Autozi Internet Technology's shares surged 85% following a significant investment announcement.
Global Market Trends: European and Asian markets closed higher, with notable gains in major indices, and U.S. existing home sales rose by 0.5% in November.
GeoVax Labs Seeks Approval to Offer 11.9 Million Shares of Common Stock for Shareholders
Stock Offering Announcement: GeoVax Labs filed to sell 11.9 million shares of common stock for existing holders.
Preliminary Prospectus Note: The filing is a preliminary prospectus and does not constitute an offer to sell.
Live Stream Registration Now Open for Day 2 of the Emerging Growth Conference 86 on September 25
Emerging Growth Conference Announcement: The 86th Emerging Growth Conference is scheduled for September 24 & 25, 2025, focusing on companies with strong management and growth potential across various sectors.
Keynote Speakers and Schedule: The conference features multiple keynote speakers from various companies, including Kneat.com, Zapp Electric Vehicles, and Citizens, Inc., with sessions conducted via video webcasts.
Join the Live Stream of Day 1 at the Emerging Growth Conference 85 on August 20; Registration Now Open
Emerging Growth Conference Announcement: The 85th Emerging Growth Conference is scheduled for August 20 & 21, 2025, focusing on companies with strong management and growth potential across various sectors.
Day 1 Schedule Highlights: Keynote speakers include CEOs from companies such as Immuron Limited, Nutriband, Inc., and Journey Medical Corporation, presenting their innovative products and strategies.
Day 2 Schedule Highlights: Presentations will feature executives from Eshallgo, Inc., Grove Collaborative Holdings, Inc., and U.S. Energy Corporation, among others, discussing their business developments.
Engagement and Participation: Attendees can register for the conference, submit questions to presenting companies, and access replays via the EmergingGrowth.com platform.
D. Boral Capital Maintains Buy on Geovax Labs, Maintains $9 Price Target
Fastest News Alerts: Benzinga Pro offers real-time intelligence and news alerts to help traders stay informed and make winning trades in the stock market.
Exclusive Community Access: Joining Benzinga Pro connects users with over 10,000 serious traders and provides access to exclusive stories and insights from Benzinga reporters.
Tilray Brands Reports Q2 Earnings Beat, Shares Surge 7.3%
- Earnings Beat: Tilray Brands reported Q2 earnings of $0.01 per share, surpassing the market expectation of a $0.20 loss, indicating a significant improvement in profitability that boosts investor confidence.
- Revenue Growth: The company achieved quarterly revenue of $217.51 million, exceeding the consensus estimate of $210.95 million, demonstrating success in market demand and sales strategies, which further solidifies its market position.
- Stock Price Surge: Following the positive earnings report, Tilray Brands' shares rose 7.3% to $9.80 in pre-market trading, reflecting investor optimism about the company's future growth potential.
- Positive Market Reaction: The strong performance post-earnings release may attract more investor attention, enhancing the company's appeal in a competitive market landscape.
Dow Rises by More Than 200 Points; Conagra Stock Declines Following Q2 Earnings Report
U.S. Stock Market Performance: U.S. stocks rose this morning, with the Dow Jones gaining over 200 points, while the NASDAQ and S&P 500 also saw increases of 1.03% and 0.73%, respectively.
Sector Movements: Information technology shares increased by 1.6%, while real estate stocks experienced a slight decline of 0.1%.
Notable Stock Movements: Conagra Brands Inc. shares fell over 4% despite beating earnings estimates, while Autozi Internet Technology's shares surged 85% following a significant investment announcement.
Global Market Trends: European and Asian markets closed higher, with notable gains in major indices, and U.S. existing home sales rose by 0.5% in November.
GeoVax Labs Seeks Approval to Offer 11.9 Million Shares of Common Stock for Shareholders
Stock Offering Announcement: GeoVax Labs filed to sell 11.9 million shares of common stock for existing holders.
Preliminary Prospectus Note: The filing is a preliminary prospectus and does not constitute an offer to sell.
Live Stream Registration Now Open for Day 2 of the Emerging Growth Conference 86 on September 25
Emerging Growth Conference Announcement: The 86th Emerging Growth Conference is scheduled for September 24 & 25, 2025, focusing on companies with strong management and growth potential across various sectors.
Keynote Speakers and Schedule: The conference features multiple keynote speakers from various companies, including Kneat.com, Zapp Electric Vehicles, and Citizens, Inc., with sessions conducted via video webcasts.
Join the Live Stream of Day 1 at the Emerging Growth Conference 85 on August 20; Registration Now Open
Emerging Growth Conference Announcement: The 85th Emerging Growth Conference is scheduled for August 20 & 21, 2025, focusing on companies with strong management and growth potential across various sectors.
Day 1 Schedule Highlights: Keynote speakers include CEOs from companies such as Immuron Limited, Nutriband, Inc., and Journey Medical Corporation, presenting their innovative products and strategies.
Day 2 Schedule Highlights: Presentations will feature executives from Eshallgo, Inc., Grove Collaborative Holdings, Inc., and U.S. Energy Corporation, among others, discussing their business developments.
Engagement and Participation: Attendees can register for the conference, submit questions to presenting companies, and access replays via the EmergingGrowth.com platform.
D. Boral Capital Maintains Buy on Geovax Labs, Maintains $9 Price Target
Fastest News Alerts: Benzinga Pro offers real-time intelligence and news alerts to help traders stay informed and make winning trades in the stock market.
Exclusive Community Access: Joining Benzinga Pro connects users with over 10,000 serious traders and provides access to exclusive stories and insights from Benzinga reporters.
